NEPH
Price
$3.57
Change
-$0.02 (-0.56%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
38.99M
14 days until earnings call
Intraday BUY SELL Signals
SGHT
Price
$9.10
Change
+$0.40 (+4.60%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
479.27M
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NEPH vs SGHT

NEPH vs SGHT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NEPH vs. SGHT commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEPH is a StrongBuy and SGHT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NEPH with price predictions
Oct 21, 2026

NEPH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for NEPH turned positive on October 16, 2026. Looking at past instances where NEPH's MACD turned positive, the stock continued to rise in 35 of 43 cases over the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NEPH's RSI Oscillator exited the oversold zone, 19 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on NEPH as a result. In 74 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

Following a +2.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEPH advanced for three days, in 164 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

NEPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

NEPH moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NEPH crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for NEPH entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.258) is normal, around the industry mean (4.952). P/E Ratio (22.438) is within average values for comparable stocks, (36.644). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.318) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. NEPH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for SGHT with price predictions
Oct 21, 2026

SGHT in downward trend: price expected to drop as it breaks its higher Bollinger Band on September 25, 2026

SGHT broke above its upper Bollinger Band on September 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 33 similar instances where the stock broke above the upper band. In 29 of the 33 cases the stock fell afterwards. This puts the odds of success at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SGHT moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 23 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Moving Average Convergence Divergence Histogram (MACD) for SGHT turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 66 cases where SGHT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on SGHT as a result. In 73 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

SGHT moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +5.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where SGHT advanced for three days, in 209 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

The Aroon Indicator entered an Uptrend today. In 114 of 126 cases where SGHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.061) is normal, around the industry mean (2.923). P/E Ratio (-15.818) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (5.222) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. SGHT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGHT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
NEPH: Fundamental Ratings
NEPH
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
53
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEPHSGHT
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
80%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (NEPH: $3.59 vs. SGHT: $8.70)
Brand notoriety: NEPH and SGHT are both not notable
NEPH represents the Pharmaceuticals: Other, while SGHT is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NEPH: 41% vs. SGHT: 55%
Market capitalization -- NEPH: $38.23M vs. SGHT: $500.75M
NEPH [@Pharmaceuticals: Other] is valued at $38.23M. SGHT’s [@Medical/Nursing Services] market capitalization is $500.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEPH’s FA Score shows that 0 FA rating(s) are green while SGHT’s FA Score has 1 green FA rating(s).

  • NEPH’s FA Score: 0 green, 5 red.
  • SGHT’s FA Score: 1 green, 4 red.
According to our system of comparison, SGHT is a better buy in the long-term than NEPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEPH’s TA Score shows that 5 TA indicator(s) are bullish while SGHT’s TA Score has 5 bullish TA indicator(s).

  • NEPH’s TA Score: 5 bullish, 5 bearish.
  • SGHT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SGHT is a better buy in the short-term than NEPH.

Price Growth

NEPH (@Pharmaceuticals: Other) experienced а +1.99% price change this week, while SGHT (@Medical/Nursing Services) price change was +5.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

NEPH is expected to report earnings on Nov 05, 2026.

SGHT is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
NEPH
Daily Signal:
Gain/Loss:
SGHT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with SGHT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
+1.99%
SGHT - NEPH
34%
Loosely correlated
+0.93%
IMDX - NEPH
31%
Poorly correlated
-0.33%
GH - NEPH
28%
Poorly correlated
+2.50%
LUCY - NEPH
27%
Poorly correlated
+4.44%
AZTA - NEPH
25%
Poorly correlated
+2.88%
More

SGHT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGHT has been loosely correlated with SMTI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SGHT jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGHT
1D Price
Change %
SGHT100%
+0.93%
SMTI - SGHT
42%
Loosely correlated
-1.12%
UTMD - SGHT
42%
Loosely correlated
-0.47%
TWST - SGHT
41%
Loosely correlated
+4.51%
RDNT - SGHT
39%
Loosely correlated
-1.78%
XRAY - SGHT
37%
Loosely correlated
+2.37%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPME24.58-0.08
-0.32%
Sound Point Meridian Capital Inc
IBRX8.64-0.13
-1.48%
ImmunityBio
KARO61.47-1.18
-1.88%
Karooooo Ltd
APT5.44-0.12
-2.16%
Alpha Pro Tech Ltd
OTLY12.23-0.55
-4.30%
Oatly Group AB